510(k) · Cleared
ClearedGFX Nerve Ablation System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Aci, Inc. · GXD Generator, Lesion, Radiofrequency
Cleared on Jun 20, 2007 as substantially equivalent to K965182 (Radionics, Inc., 1997) and 1 other predicate after a 183-day review. Its family tree reaches back 1 generation to 1997. 1 later device descends from it.
- Decided
- Jun 20, 2007
- Review
- 183 days
- Class
- Class II
- Product code
- GXD
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 1 generation to K965182 (1997). 2 ancestors in all. 1 later device descends from it, 1 citing it directly.
Most influential descendants
Showing 1 of 1 · See all- K081729Modification to GFX Nerve Ablation SystemBioform Medical, Inc. · 2008 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K965182 | RFG-3CF | Radionics, Inc. | 1997 | — |
| 0 (this device) | K063753 | GFX Nerve Ablation System | Aci, Inc. | 2007 | — |
| +1 | K081729 | Modification to GFX Nerve Ablation System | Bioform Medical, Inc. | 2008 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2000 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2008 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in GXD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new GXD device
- #1 K251247 GX1 Radiofrequency Generator Kit…score 11.0 · 5 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K965182 | RFG-3CFSummary page 1…: Class II E. Device Code: GXD (proposed) (21 CFR 882.4400) PREDICATE DEVICES Trade Name: Radionics RFG-3CF 510(k) Number: K965182 Trade Name: Mercury Medical Disposable RF Cannula 5 10(k) Number: K000073 DEVICE DESCRIPTION GFX Nerve Ablatio… | 1997 |
| * | K000073 | Mercury Medical Disposable Radiofrequency CannulaSummary page 1…82.4400) PREDICATE DEVICES Trade Name: Radionics RFG-3CF 510(k) Number: K965182 Trade Name: Mercury Medical Disposable RF Cannula 5 10(k) Number: K000073 DEVICE DESCRIPTION GFX Nerve Ablation System (generator and probe): The GFX Nerve Ablation System provides a minimall… | 2000 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K081729 | Modification to GFX Nerve Ablation System | 2008 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All GXD devicesGXD Generator, Lesion, Radiofrequency: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.
FDA decisions per year · GXD
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · GXD
185in 2007
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · GXD
1in 2023
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · GXD
88in 2025
MAUDE reports naming product code GXD, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 4 | 185 | 0 | 10 |
| 2008 | 2 | — | 0 | 10 |
| 2009 | 0 | — | 0 | 12 |
| 2010 | 1 | — | 1 | 69 |
| 2011 | 2 | — | 0 | 89 |
| 2012 | 0 | — | 0 | 77 |
| 2013 | 0 | — | 0 | 119 |
| 2014 | 0 | — | 0 | 64 |
| 2015 | 0 | — | 0 | 67 |
| 2016 | 0 | — | 1 | 51 |
| 2017 | 2 | — | 0 | 83 |
| 2018 | 0 | — | 0 | 156 |
| 2019 | 1 | — | 1 | 195 |
| 2020 | 2 | — | 0 | 138 |
| 2021 | 0 | — | 0 | 154 |
| 2022 | 1 | — | 0 | 84 |
| 2023 | 2 | — | 1 | 54 |
| 2024 | 2 | — | 0 | 63 |
| 2025 | 1 | — | 0 | 88 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The Lesion Probe and Generator system is intended to create radiofrequency (RF) heat lesions in nerve tissue. It is intended for use only by trained clinicians in a hospital or clinical setting.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K063753 · printed Nov 6, 2026
Cite this page
510(k) Report. “K063753: GFX Nerve Ablation System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K063753
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026